SpaceX Is Pushing Ahead With Its IPO Plans, And The Biotech Sector Has Seen The Most Dealmaking In A Decade episode artwork

EPISODE · Dec 11, 2025 · 6 MIN

SpaceX Is Pushing Ahead With Its IPO Plans, And The Biotech Sector Has Seen The Most Dealmaking In A Decade

from The Finimize Daily Brief · host Finimize

SpaceX is pushing ahead with its initial public offering plans – a bid to raise some $30 billion and land in the $1.5 trillion club – while the biotech sector has seen the most mergers and acquisitions in a decade, as pharma firms race against an expiry date.Today’s stories:SpaceX Is Preparing For Its Public Market Launch DayPharma Firms Rushed To Restock Before Their Pipelines Run DryTry Finimize Pro

Episode metadata supplied by the publisher feed · Published Dec 11, 2025

Embed this episode

NOW PLAYING

SpaceX Is Pushing Ahead With Its IPO Plans, And The Biotech Sector Has Seen The Most Dealmaking In A Decade

0:00 6:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Finimize Daily Brief?

This episode is 6 minutes long.

When was this The Finimize Daily Brief episode published?

This episode was published on December 11, 2025.

Can I download this The Finimize Daily Brief episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!